Jacobovitz Shalom 4
Research Summary
AI-generated summary
Clene (CLNN) Director Jacobovitz Receives 4,098-Share Option Award
What Happened
- Director Shalom Jacobovitz (reported as Jacobovitz Shalom) received a grant of options for 4,098 shares of Clene Inc. common stock on February 19, 2026. The Form 4 shows an acquisition via award (derivative instrument) with no cash paid at grant.
- Per the filing footnote, the options were granted under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share and vest immediately upon grant. Because this is an option award, no shares were sold or purchased on the open market.
Key Details
- Transaction date: 2026-02-19 (reported on Form 4 filed 2026-02-20)
- Grant: options for 4,098 shares; exercise price $4.73 per share; grant reported as $0.00 cash paid at issuance
- Vesting: options vest immediately (per footnote)
- Shares owned after transaction: not specified in the filing
- Filing timeliness: filed one day after the transaction date (no late filing indicated)
- Footnote: grant made under the Clene Inc. Amended 2020 Stock Plan
Context
- This was an option grant (a derivative award). Options give the holder the right to buy shares later at the exercise price; they do not represent immediate ownership until exercised and shares issued.
- Such grants are typically a form of compensation or retention for insiders; they are not the same as an open-market purchase, and do not necessarily indicate immediate buying or selling intent.